BR9806213A - Forma de dosagem transdérmica. - Google Patents

Forma de dosagem transdérmica.

Info

Publication number
BR9806213A
BR9806213A BR9806213-1A BR9806213A BR9806213A BR 9806213 A BR9806213 A BR 9806213A BR 9806213 A BR9806213 A BR 9806213A BR 9806213 A BR9806213 A BR 9806213A
Authority
BR
Brazil
Prior art keywords
transdermal dosage
dosage form
transdermal
relates
present
Prior art date
Application number
BR9806213-1A
Other languages
English (en)
Inventor
Alfred J Moo-Young
Yun-Yen-Tsong
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Publication of BR9806213A publication Critical patent/BR9806213A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"FORMA DE DOSAGEM TRANSDéRMICA". A presente invenção diz respeito a formas de dosagem transdérmica (10) para liberação de androgênios.
BR9806213-1A 1997-09-17 1998-09-17 Forma de dosagem transdérmica. BR9806213A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5930197P 1997-09-17 1997-09-17
US09/154,287 US20020012694A1 (en) 1997-09-17 1998-09-16 Transdermal administration of ment
PCT/US1998/019399 WO1999013812A1 (en) 1997-09-17 1998-09-17 Transdermal administration of ment

Publications (1)

Publication Number Publication Date
BR9806213A true BR9806213A (pt) 2000-04-18

Family

ID=26738606

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9806213-1A BR9806213A (pt) 1997-09-17 1998-09-17 Forma de dosagem transdérmica.

Country Status (6)

Country Link
US (2) US20020012694A1 (pt)
EP (1) EP0941039A4 (pt)
JP (1) JP2001527581A (pt)
BR (1) BR9806213A (pt)
CA (1) CA2270177C (pt)
WO (1) WO1999013812A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100452972B1 (ko) 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
WO2003068314A1 (en) * 2002-02-15 2003-08-21 Pantarhei Bioscience B.V. Pulmonary administration of 6-alpha-alkylated testosterone derivatives for androgen replacement therapy
CN100339486C (zh) * 2002-07-24 2007-09-26 舍林股份公司 制备7α－被取代的11α－羟基甾族化合物的微生物方法
DE10233723A1 (de) 2002-07-24 2004-02-12 Schering Ag Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
US7879357B2 (en) * 2003-04-28 2011-02-01 Bayer Schering Pharma Ag Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
US7056332B2 (en) * 2003-07-24 2006-06-06 Materials Evolution And Development Usa, Inc. Nucleic acid biomaterials and methods of formation and use
GB0409498D0 (en) * 2004-04-28 2004-06-02 Hunter Fleming Ltd Transdermal steroid formulation
US8173152B2 (en) 2006-03-24 2012-05-08 Auxilium Us Holdings, Llc Stabilized compositions containing alkaline labile drugs
JP5336351B2 (ja) 2006-03-24 2013-11-06 オクシリウム インターナショナル ホールディングス，インコーポレイティド ホットメルト押出しラミネートの調製方法
US20070243714A1 (en) * 2006-04-18 2007-10-18 Applied Materials, Inc. Method of controlling silicon-containing polymer build up during etching by using a periodic cleaning step
EP3670561B1 (en) 2009-01-12 2023-12-06 University Of Massachusetts Lowell Polyisobutylene-based polyurethanes
US8529934B2 (en) * 2009-08-21 2013-09-10 Boston Scientific Scimed, Inc. Crosslinkable polyisobutylene-based polymers and medical devices containing the same
US8374704B2 (en) 2009-09-02 2013-02-12 Cardiac Pacemakers, Inc. Polyisobutylene urethane, urea and urethane/urea copolymers and medical leads containing the same
US8644952B2 (en) 2009-09-02 2014-02-04 Cardiac Pacemakers, Inc. Medical devices including polyisobutylene based polymers and derivatives thereof
US9484123B2 (en) 2011-09-16 2016-11-01 Prc-Desoto International, Inc. Conductive sealant compositions
CN104520345B (zh) 2012-11-21 2017-10-03 马萨诸塞州大学 高强度聚氨异丁烯聚氨甲酸酯
EP3592786B1 (en) 2017-03-07 2023-05-10 Cardiac Pacemakers, Inc. Hydroboration/oxidation of allyl-terminated polyisobutylene
WO2019036544A1 (en) 2017-08-17 2019-02-21 Cardiac Pacemakers, Inc. PHOTORÉTICULATED POLYMERS FOR IMPROVED DURABILITY
US11472911B2 (en) 2018-01-17 2022-10-18 Cardiac Pacemakers, Inc. End-capped polyisobutylene polyurethane

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177267A (en) * 1963-12-09 1979-12-04 Crown Zellerbach Enhancing tissue penetration of physiologically active steroidal agents with DMSC
AU565354B2 (en) * 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5342834A (en) * 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
EP0500287B1 (en) * 1991-02-20 1995-04-26 Hitachi, Ltd. Catalyzer control apparatus
US5332576A (en) * 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
AU678237B2 (en) * 1993-04-20 1997-05-22 Hexal Pharma Gmbh Active substance-containing plaster
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
US5733565A (en) * 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant

Also Published As

Publication number Publication date
WO1999013812A1 (en) 1999-03-25
US20020012694A1 (en) 2002-01-31
EP0941039A4 (en) 2006-06-21
CA2270177C (en) 2006-08-29
CA2270177A1 (en) 1999-03-25
US20040126418A1 (en) 2004-07-01
JP2001527581A (ja) 2001-12-25
EP0941039A1 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
BR9806213A (pt) Forma de dosagem transdérmica.
HN1998000115A (es) Formas de dosificación farmacéuticas sólidas
IT1317782B1 (it) Insieme per fibbia ad alta sicurezza
HN1998000132A (es) Combinaciones terapeuticas
ATA398A (de) Ratschenschnalle
IT1307274B1 (it) Fibbia.
HN1998000124A (es) Terapia de combinacion
IT1307057B1 (it) Fibbia.
HN1998000099A (es) Formas de dosificacion de sertralina de liberacion retardada
BG106316A (en) Ambroxol-containing lozenge
BR9814127A (pt) Nova forma de dosagem oral para carvedilol
BR9808642A (pt) Processo para preparar eprosartan
BR9808664A (pt) Processo para preparar eprosartan
NO996520D0 (no) Opploeste sertralinblandinger
ES1032083Y (es) Hebilla para cinturon.
BR9813048B1 (pt) processo para a preparação de um composto.
ID20524A (id) Rem teromol
HN1998000103A (es) Sales de sertralina y formas de dosificacion de liberacion sostenida de sertralina
ECSP972265A (es) Dihidrato de d-olanzapina
HN1997000147A (es) Procedimientos para piridinas sustituidas
ES1038294Y (es) Pinza para estampacion de matriculas.
BR9700320A (pt) Composto vitaminico para utilização no couro cabeludo
HN1999000192A (es) Antagonistas de 54t1 para terapia antidepresiva
ES1043262Y (es) Dispositivo para la proteccion de un articulo contra hurtos.
ES1035037Y (es) Dispositivo de abroche para calzado.

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA A CLASSIFICACAO PARA A61K 9/00 E A61F 13/00

Ipc: A61K 9/00, A61F 13/00

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 9/06, A61K 9/12, A61K 9/10, A61K 9/14, A61K 9/70, A61K 31/575, A61L 15/44, A61P 5/24, A61P 19/10, A61P 15/18

Ipc: A61K 9/06 (2007.01), A61K 9/12 (2007.01), A61K 9/1

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DE ACORDO COM ART. 8O DA LPI.